ELV

291.63

1.30% 3.74

Dopo l'orario di chiusura: 288.00 -3.63 -1.24%

Elevance Health Inc (ELV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ELV Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$287.89

Aprire:

$291.32

Volume 24 ore:

2.36M

Relative Volume:

1.26

Capitalizzazione di mercato:

$64.36B

Reddito:

$199.13B

Utile/perdita netta:

$5.66B

Rapporto P/E:

11.61

EPS:

25.1089

Flusso di cassa netto:

$3.17B

1 W Prestazione:

+0.69%

1M Prestazione:

-15.91%

6M Prestazione:

-6.46%

1 anno Prestazione:

-30.11%

Intervallo 1D:

$289.60

$294.43

Intervallo di 1 settimana:

$274.84

$295.79

Portata 52W:

$273.71

$458.73

Elevance Health Inc Stock (ELV) Company Profile

Nome

Elevance Health Inc

Settore

Healthcare (1116)

Industria

Healthcare Plans (12)

Telefono

(800) 331-1476

Indirizzo

220 VIRGINIA AVENUE, INDIANAPOLIS

Dipendente

97,100

Cinguettio

Prossima data di guadagno

2026-04-28

Ultimi documenti SEC

ELV's Discussions on Twitter

Compare ELV vs UNH, CVS, CI, HUM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ELV Elevance Health Inc	291.63	64.36B	199.13B	5.66B	3.17B	25.11
UNH Unitedhealth Group Inc	282.09	256.05B	447.57B	12.81B	16.08B	13.19
CVS Cvs Health Corp	76.13	96.85B	402.11B	1.73B	7.81B	1.3835
CI Cigna Group	267.19	70.41B	274.88B	6.29B	8.39B	22.19
HUM Humana Inc	165.43	19.86B	126.36B	1.30B	1.55B	10.67

Elevance Health Inc Stock (ELV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-03	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2026-01-08	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-12-19	Downgrade	Deutsche Bank	Buy → Hold
2025-10-14	Iniziato	Goldman	Neutral
2025-07-21	Downgrade	Argus	Buy → Hold
2025-07-18	Downgrade	Leerink Partners	Outperform → Market Perform
2025-04-15	Downgrade	Robert W. Baird	Outperform → Neutral
2025-03-17	Aggiornamento	Argus	Hold → Buy
2025-01-22	Downgrade	Stephens	Overweight → Equal-Weight
2024-10-18	Downgrade	Argus	Buy → Hold
2024-07-18	Downgrade	BofA Securities	Buy → Neutral
2024-06-24	Iniziato	Morgan Stanley	Overweight
2024-05-30	Iniziato	Robert W. Baird	Outperform
2024-03-06	Iniziato	Barclays	Overweight
2023-07-12	Downgrade	Wolfe Research	Outperform → Peer Perform
2023-04-27	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-04-21	Iniziato	Cantor Fitzgerald	Overweight
2023-03-28	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2022-09-09	Aggiornamento	BofA Securities	Neutral → Buy
2022-08-22	Aggiornamento	SVB Leerink	Mkt Perform → Outperform

Mostra tutto

Elevance Health Inc Borsa (ELV) Ultime notizie

Mar 14, 2026

Elevance Health Inc Stock (ISIN: US0367521038) Faces Pressure Amid Analyst Target Cuts and Mixed Ins - AD HOC NEWS

Mar 14, 2026

Mar 13, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Mar 13, 2026

Elevance Health Stock Faces Headwinds Amid Medicare Sanctions and Mixed Analyst Views - AD HOC NEWS

Mar 13, 2026

Quadrature Capital Ltd Boosts Elevance Health Stake - National Today

Mar 13, 2026

Mar 12, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Mar 12, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elevance Health, Inc.ELV - PR Newswire

Mar 12, 2026

Bernstein SocGen cuts Elevance stock price target on Medicare sanctions - Investing.com

Mar 12, 2026

Bernstein Adjusts Price Target on Elevance Health to $384 From $409, Maintains Outperform Rating - marketscreener.com

Mar 12, 2026

Bank of Montreal Can Boosts Elevance Health Stake - National Today

Mar 12, 2026

Bank of Montreal Can Grows Holdings in Elevance Health, Inc. $ELV - MarketBeat

Mar 12, 2026